Meeting minutes
Oregon Prescription Drug Affordability Board · February 18, 2026
At its Feb. 18, 2026 meeting the Oregon Prescription Drug Affordability Board adopted revised Policies and Procedures, discussed House Bill 4040 provisions on insulin-product identification, received a program update and public comments from industry and consumer groups, and reviewed preliminary 2026 drug review lists based on 2024 insurer reporting.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.